View in EDS

Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.

Saved in:
Bibliographic Details
Title: Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.
Authors: Haykal MM; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France., Rodrigues-Ferreira S; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France; Inovarion, 75005, Paris, France., El Botty R; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France., Sourd L; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France., Marangoni E; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France., Varin M; IKTOS, 75017, Paris, France., Denis A; IKTOS, 75017, Paris, France., Nahmias C; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France. Electronic address: clara.nahmias@inserm.fr.
Source: Cancer letters [Cancer Lett] 2025 Jun 28; Vol. 620, pp. 217665. Date of Electronic Publication: 2025 Mar 22.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40127815
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Haykal+MM%22">Haykal MM</searchLink>; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France.<br /><searchLink fieldCode="AU" term="%22Rodrigues-Ferreira+S%22">Rodrigues-Ferreira S</searchLink>; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France; Inovarion, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22El+Botty+R%22">El Botty R</searchLink>; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sourd+L%22">Sourd L</searchLink>; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Translational Research Department, Institut Curie, PSL University, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Varin+M%22">Varin M</searchLink>; IKTOS, 75017, Paris, France.<br /><searchLink fieldCode="AU" term="%22Denis+A%22">Denis A</searchLink>; IKTOS, 75017, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nahmias+C%22">Nahmias C</searchLink>; Institut Gustave Roussy, Inserm U981, Biomarqueurs prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France; Université Paris-Saclay, 91400, Orsay, France. Electronic address: clara.nahmias@inserm.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2025 Jun 28; Vol. 620, pp. 217665. <i>Date of Electronic Publication: </i>2025 Mar 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40127815
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.canlet.2025.217665
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 217665
    Titles:
      – TitleFull: Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Haykal MM
      – PersonEntity:
          Name:
            NameFull: Rodrigues-Ferreira S
      – PersonEntity:
          Name:
            NameFull: El Botty R
      – PersonEntity:
          Name:
            NameFull: Sourd L
      – PersonEntity:
          Name:
            NameFull: Marangoni E
      – PersonEntity:
          Name:
            NameFull: Varin M
      – PersonEntity:
          Name:
            NameFull: Denis A
      – PersonEntity:
          Name:
            NameFull: Nahmias C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 06
              Text: 2025 Jun 28
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7980
          Numbering:
            – Type: volume
              Value: 620
          Titles:
            – TitleFull: Cancer letters
              Type: main
ResultId 1